Tekla Capital Management LLC Wave Life Sciences Ltd. Transaction History

Tekla Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$8.49 - $19.54 $1.09 Million - $2.5 Million	-128,146 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$6.94 - $14.22 $195,249 - $400,065	28,134 Added 28.13%	128,146 $1.2 Million
Q4 2019 Feb 13, 2020	SELL	$7.99 - $37.6 $180,086 - $847,466	-22,539 Reduced 18.39%	100,012 $802,000
Q3 2019 Nov 13, 2019	BUY	$19.17 - $27.4 $1.28 Million - $1.82 Million	66,596 Added 119.02%	122,551 $2.52 Million
Q2 2019 Aug 14, 2019	BUY	$22.93 - $42.84 $587,443 - $1.1 Million	25,619 Added 84.45%	55,955 $1.46 Million
Q1 2019 May 14, 2019	BUY	$32.69 - $47.91 $991,683 - $1.45 Million	30,336 New	30,336 $1.18 Million

146

93.1M

33K

57.2K

Ticker WVE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,820,096
Market Cap $720M
Description
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Tekla Capital Management LLC with notifications on news.